At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
TransLoc electrodedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Early Feasibility Clinical Study to Investigate the Safety and Performance of TransLoc® Electrodes for Temporary Diaphragm Pacing in Patients Undergoing Surgical Procedures
In Brief
A clinical study evaluating TransLoc electrode for Diaphragm Pacing. Completed, enrolled 12 participants across 1 site.
Detailed Summary
Feasibility study to advance the development of NeuRx Diaphragm Pacing System (DPS) for the intended use of stimulating the diaphragm to provide respiratory assistance in patients at risk of prolonged mechanical ventilation in the Intensive Care Unit (ICU).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiaphragm Pacing
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2015
Enrollment StartMay 2015
Primary CompletionAug 2015
TodayJul 2026
First PostedApr 8, 2015
Enrollment StartMay 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.2 years ago
Interventions
TransLoc electrodedevice
Patients will have 2 electrodes placed in either side of the diaphragm (total 4 electrodes) during their primary surgery.